Hyalolex: a combination of three powerful natural ingredients
• Powerful ingredients that have been shown in studies to be neuroprotective, increase mitochondrial functioning in neurons, reduce plaques, reduce tangles, and help enhance spatial memory. (Cao et al 2014)
• Studies show that the ingredients can also help manage Alzheimer’s symptoms like anxiety, aggression, depression, sleep disorder, apathy, night time agitation, and reduce overall caregiver distress. (Shelef et al 2016)
• Hyalolex is designed for a gentler journey in caring for patients with Alzheimer’s. It contains THC, which is a cannabinoid derived from cannabis that in low doses will not make you high or unproductive.
• There are two patents filed on Hyalolex.
Why take Hyalolex?
50% of Alzheimer’s disease (AD) patients suffer from agitation. (Tariot1999)
Motor activity and agitation is higher in AD patients than normal subjects. (Voliceret et al. 2001)
About 50% of patients with severe AD develop day-night rhythm disturbance or agitated behavior during the evening hours. (Hope et al. 1999)
Reduce sleep disturbance
AD patients suffer from night time agitation and night time behavioral disorder. (Woodward et al 2014)
A leading cause of hospitalization in AD patients is sun downing syndrome. (Ferrazzoli et al 2013)
BPSD: Behavioral and psychological symptoms of dementia includes delusions, depression, anxiety, apathy/indifference, disinhibition, and irritability. (Shelef et al 2016)
Reduce caregiver distress
30% of the cost of treating AD patients is the cost of caregivers.
As AD advances patients become hard to manage and care for.
Dosage for Hyalolex
For mild and at risk AD patients: 1 ml per day on an empty stomach.
For moderate AD patients: 1 ml twice a day on an empty stomach.
For severe AD patients: 1 ml three times a day on an empty stomach.
What is Alzheimer’s Disease ?
Medicare and Medicaid alone are expected to spend over $200 billion on patients diagnosed with Alzheimer’s.The number of patients is predicted to double over the next 20 years and the direct costs are projected to reach $1 trillion per year.
Alzheimer’s is a complex neurodegenerative disease that is a Protein Misfolding Disease (MFD) that is believed to account for 60% to 70% of dementia. Other MFDs include Parkinson’s, cataracts, cystic fibrosis, sickle cell disease, among others. It starts 20 to 30 years before many of the more severe neurodegenerative symptoms manifest.
About 1 to 5% of Alzheimer’s is early onset Alzheimer’s (EOAD). It is determined by a defect on chromosome 14. The more common remaining 95% is known as Sporadic Alzheimer’s and is not linked to genetics. There are many theories for the etiology of Alzheimer’s including prion infection, Aβ amyloid cascade hypothesis, Tau protein hyperphosphorylation, mitochondria cascade hypothesis, among others. While dementia was always associated with old age, it was not until 1907 that Alzheimer’s disease was identified.
There is no cure for Alzheimer’s disease
Stages of Alzheimer's
Historically, a histopathological study led the German psychiatrist Alois Alzheimer to first report the disease. He found that the brain of his patient had distinctive plaques and tangles. The senile plaques are extra cellular deposits rich in Aβ protein aggregates, and the intracellular tangles are caused by a break down of the protein tau.